| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling Asherson’s syndrome
|
Roncati, Luca
|
|
|
52 |
4 |
p. 1043-1046
|
artikel
|
| 2 |
Analysis of changes in the expression pattern of miR-326 and miR-145 during storage of platelet concentrate in blood bank condition and its relationship with some markers of platelet quality
|
Norouzi, Mozhgan
|
|
|
52 |
4 |
p. 1036-1042
|
artikel
|
| 3 |
Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
|
Fang, Margaret C.
|
|
|
52 |
4 |
p. 1101-1109
|
artikel
|
| 4 |
A rare case of non-traumatic spinal epidural hematoma in lumbar region associated with apixaban therapy
|
Krupa, Petr
|
|
|
52 |
4 |
p. 1215-1219
|
artikel
|
| 5 |
Association of serum uric acid with mortality and cardiovascular outcomes in patients with hypertension: a meta-analysis
|
Yang, Yong
|
|
|
52 |
4 |
p. 1084-1093
|
artikel
|
| 6 |
Comparison of potential pharmacokinetic drug interactions in patients with atrial fibrillation and changing from warfarin to non-vitamin K oral anticoagulant therapy
|
Bernaitis, Nijole
|
|
|
52 |
4 |
p. 1110-1116
|
artikel
|
| 7 |
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles
|
Becker, Richard C.
|
|
|
52 |
4 |
p. 1010-1019
|
artikel
|
| 8 |
Double positivity of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies enhances both thrombosis and positivity of anti-ADAMTS13 antibody
|
Yun, Jiwon
|
|
|
52 |
4 |
p. 1133-1136
|
artikel
|
| 9 |
External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19
|
Goldin, Mark
|
|
|
52 |
4 |
p. 1032-1035
|
artikel
|
| 10 |
Hospitalization for venous thromboembolic disease management: a 10 years Registry in Buenos Aires, Argentina
|
Vázquez, Fernando Javier
|
|
|
52 |
4 |
p. 1187-1194
|
artikel
|
| 11 |
Impact of antithrombin III and enoxaparin dosage adjustment on prophylactic anti-Xa concentrations in trauma patients at high risk for venous thromboembolism: a randomized pilot trial
|
Droege, Molly Elizabeth
|
|
|
52 |
4 |
p. 1117-1128
|
artikel
|
| 12 |
Impact of the pandemic of COVID-19 on emergency attendance for stroke and acute myocardial infarction in Beijing, China
|
Wu, Yiqun
|
|
|
52 |
4 |
p. 1047-1055
|
artikel
|
| 13 |
Incidence of thrombotic complications in COVID-19
|
Jenner, William J.
|
|
|
52 |
4 |
p. 999-1006
|
artikel
|
| 14 |
International COVID-19 biomarkers colloquium
|
Becker, Richard C.
|
|
|
52 |
4 |
p. 983-984
|
artikel
|
| 15 |
International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests
|
Gurbel, Paul A.
|
|
|
52 |
4 |
p. 992-998
|
artikel
|
| 16 |
Is an antithrombotic strategy after transcatheter aortic valve implantation clearer now?
|
Lv, Meina
|
|
|
52 |
4 |
p. 1160-1164
|
artikel
|
| 17 |
Management of tandem occlusions in patients who receive rtPA
|
Smetana, Keaton S.
|
|
|
52 |
4 |
p. 1182-1186
|
artikel
|
| 18 |
Meta-analysis of restrictive versus liberal blood transfusion among patients with coronary artery disease
|
Kheiri, Babikir
|
|
|
52 |
4 |
p. 1081-1083
|
artikel
|
| 19 |
Patient perceptions of anticoagulant treatment with dabigatran or a vitamin K antagonist for stroke prevention in atrial fibrillation according to region and age: an exploratory analysis from the RE-SONANCE study
|
Vinereanu, Dragos
|
|
|
52 |
4 |
p. 1195-1206
|
artikel
|
| 20 |
Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale
|
Eisenson, Daniel L.
|
|
|
52 |
4 |
p. 1056-1060
|
artikel
|
| 21 |
Primary pulmonary artery sarcoma versus pulmonary thromboembolism: a multimodal imaging comparison
|
Kronzer, Ellen
|
|
|
52 |
4 |
p. 1129-1132
|
artikel
|
| 22 |
Prior use of anticoagulation is associated with a better survival in COVID-19
|
Buenen, A. G.
|
|
|
52 |
4 |
p. 1207-1211
|
artikel
|
| 23 |
Prothrombin complex concentrate in major bleeding associated with DOACs; an updated systematic review and meta-analysis
|
Milioglou, Ioannis
|
|
|
52 |
4 |
p. 1137-1150
|
artikel
|
| 24 |
Relationship of health literacy and adherence to oral anticoagulation therapy in patients with atrial fibrillation: a cross‐sectional study
|
Bartolazzi, Frederico
|
|
|
52 |
4 |
p. 1074-1080
|
artikel
|
| 25 |
Routine screening for pulmonary embolism in COVID-19 patients at the emergency department: impact of D-dimer testing followed by CTPA
|
Korevaar, Daniël A.
|
|
|
52 |
4 |
p. 1068-1073
|
artikel
|
| 26 |
Ruthenium chloride inhibits the anticoagulant activity of the phospholipase A2-dependent neurotoxin of Mojave rattlesnake Type A venom
|
Nielsen, Vance G.
|
|
|
52 |
4 |
p. 1020-1022
|
artikel
|
| 27 |
Safety and efficacy of catheter-directed therapy versus anticoagulation alone in a higher-risk acute pulmonary embolism population
|
Putnam, Andrew
|
|
|
52 |
4 |
p. 1151-1159
|
artikel
|
| 28 |
Safety of intravenous thrombolysis in stroke of unknown time of onset: A systematic review and meta-analysis
|
Wang, Chen
|
|
|
52 |
4 |
p. 1173-1181
|
artikel
|
| 29 |
Screening for venous thromboembolism in patients with COVID-19
|
Vandenbriele, Christophe
|
|
|
52 |
4 |
p. 985-991
|
artikel
|
| 30 |
Stroke risk factors and outcomes among hospitalized women with atrial fibrillation
|
Piazza, Gregory
|
|
|
52 |
4 |
p. 1023-1031
|
artikel
|
| 31 |
The characteristics and outcomes of critically Ill patients with COVID-19 who received systemic thrombolysis for presumed pulmonary embolism: an observational study
|
So, Matsuo
|
|
|
52 |
4 |
p. 1061-1067
|
artikel
|
| 32 |
The use of recombinant tissue plasminogen activator in in acute ischemic stroke is associated with increased level of BDNF
|
Soliman, Rasha
|
|
|
52 |
4 |
p. 1165-1172
|
artikel
|
| 33 |
Thrombectomy for ischemic stroke with large vessel occlusion and concomitant subarachnoid hemorrhage
|
Zivelonghi, Cecilia
|
|
|
52 |
4 |
p. 1212-1214
|
artikel
|
| 34 |
Thrombocytosis and neutrophilia associated with oxygenator failure and protamine reaction after cardiopulmonary bypass: a case report and literature review
|
Nielsen, Vance G.
|
|
|
52 |
4 |
p. 1220-1226
|
artikel
|
| 35 |
Venous and arterial thromboembolic disease in COVID-19
|
ten Berg, J.
|
|
|
52 |
4 |
p. 1007-1009
|
artikel
|
| 36 |
Venous thromboembolism in non-COVID-19 population during the pandemic: a nationwide multicenter retrospective survey
|
Qian, Cheng
|
|
|
52 |
4 |
p. 1094-1100
|
artikel
|
Tijdschrift beschrijving